The Personalized Medicine Coalition (PMC), representing a broad spectrum of academic, industrial, patient, provider, and payer communities, seeks to advance the understanding and adoption of personalized medicine concepts and products for the benefit of patients. For more information, please click here. The International Society of Pharmacogenomics (ISP) has been established to bring together investigators in the emerging new field that integrates the latest advances in genomics to clinical pharmacology and therapeutics. The International Society of Pharmacogenomics is an independent body without any affiliation to institutions, and without direct institutional/administrative ties to any companies.